CC1C(OC(=O)CCC(=O)NC(C)(C)CO)O[C@H]2OC3(C)CC[C@H]4[C@H](C)CCC1C24OO3
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?